<SEC-DOCUMENT>0001104659-25-077544.txt : 20250813
<SEC-HEADER>0001104659-25-077544.hdr.sgml : 20250813
<ACCEPTANCE-DATETIME>20250813160543
ACCESSION NUMBER:		0001104659-25-077544
CONFORMED SUBMISSION TYPE:	SCHEDULE 13G/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250813
DATE AS OF CHANGE:		20250813

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BioCardia, Inc.
		CENTRAL INDEX KEY:			0000925741
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				232753988
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-52381
		FILM NUMBER:		251211514

	BUSINESS ADDRESS:	
		STREET 1:		320 SOQUEL WAY
		CITY:			SUNNYVALE
		STATE:			CA
		ZIP:			94085
		BUSINESS PHONE:		650-226-0123

	MAIL ADDRESS:	
		STREET 1:		320 SOQUEL WAY
		CITY:			SUNNYVALE
		STATE:			CA
		ZIP:			94085

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Tiger X Medical, Inc.
		DATE OF NAME CHANGE:	20110616

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Cardo Medical, Inc.
		DATE OF NAME CHANGE:	20081027

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CLICKNSETTLE COM INC
		DATE OF NAME CHANGE:	20000823

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SATTERFIELD THOMAS A JR
		CENTRAL INDEX KEY:			0001132317
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A

	MAIL ADDRESS:	
		STREET 1:		2609 CALDWELL MILL LN
		CITY:			BIRMINGHAM
		STATE:			AL
		ZIP:			35243
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13G/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13G/A</submissionType>
    <previousAccessionNumber>0001193125-23-204468</previousAccessionNumber>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: SATTERFIELD THOMAS A JR -->
          <cik>0001132317</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>3</amendmentNo>
      <securitiesClassTitle>Common Stock, par value $0.001 per share</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>06/30/2025</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0000925741</issuerCik>
        <issuerName>BioCardia, Inc.</issuerName>
        <issuerCusip>09060U606</issuerCusip>
        <issuerPrincipalExecutiveOfficeAddress>
          <com:street1>320 Soquel Way</com:street1>
          <com:city>Sunnyvale</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>94085</com:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(c)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Thomas A. Satterfield, Jr.</reportingPersonName>
      <citizenshipOrOrganization>X1</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>153603.00</soleVotingPower>
        <sharedVotingPower>438541.00</sharedVotingPower>
        <soleDispositivePower>153603.00</soleDispositivePower>
        <sharedDispositivePower>438541.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>592144.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>9.9</classPercent>
      <typeOfReportingPerson>IN</typeOfReportingPerson>
      <comments>*Based on 5,801,224 shares of common stock of the issuer (the "Common Stock") outstanding as of August 8, 2025, as reported by the issuer in its Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2025. The Reporting Person may be deemed to beneficially own (i) 465,997 shares of Common Stock, and (ii) 283,912 warrants (the "Warrants") to purchase one share of Common Stock.  All of the Warrants are subject to a blocker provision pursuant to which the warrantholder does not have the right to exercise such Warrants if such exercise would result in beneficial ownership by the Reporting Person, together with his affiliates and any other persons acting as a group together with the Reporting Person, of more than 9.99% of the Common Stock outstanding upon such exercise, except for 17,317 Warrants that are not subject to any blocker provisions. Upon exercise, 59,262 of the Warrants (the "Sole Power Warrants"), all of which are subject to the blocker provision described above, would result in the issuance of shares of Common Stock over which the Reporting Person would have sole voting and dispositive power.

The 592,144 shares of Common Stock reported on this Schedule 13G as beneficially owned by the Reporting Person represent the 465,997 shares of Common Stock that the Reporting Person beneficially owns and 126,147 shares of Common Stock issuable upon exercise of Warrants, which collectively represent the Reporting Person's maximum beneficial ownership permissible under the applicable blocker provisions, or 9.99%. Due to field limitations of the EDGAR filing system, the percentage listed in Row 11 has been rounded down to 9.9%. This Schedule 13G assumes that the 126,147 Warrants so exercised would include all Warrants not subject to any blocker provisions and all Sole Power Warrants. If there were no limit on the Reporting Person's beneficial ownership of the issuer's Common Stock, the Reporting Person could be deemed to be the beneficial owner of an aggregate of 749,909 shares of Common Stock, representing 12.32% of the issuer's outstanding Common Stock (factoring in the exercise of such Warrants).</comments>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>BioCardia, Inc.</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>320 Soquel Way, Sunnyvale, CA 94085</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>Thomas A. Satterfield, Jr.</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>15 Colley Cove Drive
Gulf Breeze, Florida 32561</principalBusinessOfficeOrResidenceAddress>
        <citizenship>Incorporated by reference from Item 4 of the Cover Page.</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>Y</notApplicableFlag>
      </item3>
      <item4>
        <amountBeneficiallyOwned>Incorporated by reference from Item 9 of the Cover Page.</amountBeneficiallyOwned>
        <classPercent>Incorporated by reference from Item 11 of the Cover Page.</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>Incorporated by reference from Item 5 of the Cover Page.</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>Incorporated by reference from Item 6 of the Cover Page.</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>Incorporated by reference from Item 7 of the Cover Page.</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>Incorporated by reference from Item 8 of the Cover Page.</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>Y</notApplicableFlag>
      </item5>
      <item6>
        <notApplicableFlag>N</notApplicableFlag>
        <ownershipMoreThan5PercentOnBehalfOfAnotherPerson>With respect to the beneficial ownership reported for Thomas A. Satterfield, Jr., 128,309 shares of Common Stock and 128,738 shares of Common Stock issuable upon exercise of Warrants are held by Tomsat Investment &amp; Trading Co., Inc, a corporation wholly owned by Mr. Satterfield and of which he serves as President; 110,847 shares of Common Stock and 95,912 shares of Common Stock issuable upon exercise of Warrants are held by A.G. Family L.P., a partnership managed by a general partner controlled by Mr. Satterfield; and 130,000 shares of Common Stock are held by Caldwell Mill Opportunity Fund, LLC, a fund managed by an entity of which Mr. Satterfield owns a 50% interest and serves as Chief Investment Manager.

Additionally, Mr. Satterfield has a limited power of attorney for voting and disposition purposes with respect to the following shares of Common Stock: Rebecca A. Satterfield (2,500 shares). Ms. Satterfield has the right to receive or the power to direct the receipt of the proceeds from the sale of her shares.</ownershipMoreThan5PercentOnBehalfOfAnotherPerson>
      </item6>
      <item7>
        <notApplicableFlag>Y</notApplicableFlag>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>N</notApplicableFlag>
        <certifications>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.</certifications>
      </item10>
    </items>
    <signatureInformation>
      <reportingPersonName>Thomas A. Satterfield, Jr.</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Thomas A. Satterfield, Jr.</signature>
        <title>Thomas A. Satterfield, Jr.</title>
        <date>08/13/2025</date>
      </signatureDetails>
    </signatureInformation>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
